Yabao Pharmaceutical and Salus Pharma have formed a partnership to co-develop, manufacture and commercialize high technological barrier generic drugs worldwide. Yabao will exclusively own rights to commercialize certain Salus Pharma-developed products outside the U.S. and to manufacture for worldwide markets, while Salus Pharma will retain rights to commercialize in the U.S. Financial terms were not disclosed. “Yabao is excited to collaborate with Salus Pharma, a specialty pharmaceutical c...